Cas:885275-75-2 7-bromopyrazolo[1,5-a]pyridine manufacturer & supplier

Chemical Name:7-bromopyrazolo[1,5-a]pyridine

CAS.NO:885275-75-2

Synonyms:7-BROMO-PYRAZOLO[1,5-A]PYRIDINE;7-bromo-8H-pyrazolo[5,1-f]pyridine;Pyrazolo[1,5-a]pyridine,7-bromo

Molecular Formula:C₇H₅BrN₂

Molecular Weight:197.03200

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.69g/cm3

Index of Refraction:1.688

PSA:17.30000

Exact Mass:195.96400

LogP:2.09680

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 7-BROMO-PYRAZOLO[1,5-A]PYRIDINE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyrazolo[1,5-a]pyridine,7-bromo physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7-BROMO-PYRAZOLO[1,5-A]PYRIDINE Use and application,7-bromo-8H-pyrazolo[5,1-f]pyridine technical grade,usp/ep/jp grade.

Related News: As we expand our offering into the US and beyond, NOVA aims to become the go-to partner for pharma and biotech companies for in silico clinical trial support. I am delighted to welcome Grégoire to the Novadiscovery team and look forward to working closely with him.” Ombrabulin manufacturers In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks. 5-Amino-1-(3-chlorophenyl)-3-methyl-1H-pyrazole-4-carbonitrile suppliers The group, after examining Soliris’ late-stage trial data, determined they’re highly certain it produces a small benefit to patients who are positive for anti-AChR antibodies, while there’s a “moderate certainty of a small or substantial net health benefit.” 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-ol vendor & factory Dan Wygal, Country President for AstraZeneca Ireland, said: “I want to congratulate Charles River on their exciting plans to expand their Ballina site. Charles River is a long-standing strategic partner to AstraZeneca and have provided us with critical support in response to the pandemic. ,Dan Wygal, Country President for AstraZeneca Ireland, said: “I want to congratulate Charles River on their exciting plans to expand their Ballina site. Charles River is a long-standing strategic partner to AstraZeneca and have provided us with critical support in response to the pandemic.